Magenmagenulkus

H. pylori produces urease, an enzyme that converts urea in gastric juices into ammonia and carbon dioxide. The ammonia neutralizes the acidity around the bacteria, creating a protective microenvironment. This adaptation allows the bacterium to colonize the gastric mucosa and establish chronic infection.

VacA and CagA are major virulence factors produced by H. pylori. VacA induces apoptosis in epithelial cells, while CagA triggers the release of pro-inflammatory cytokines that recruit neutrophils. Together, these toxins amplify tissue damage and drive chronic inflammation that compromises the protective mucus barrier.

Chronic inflammation from persistent H. pylori infection erodes the protective mucus layer and reduces bicarbonate secretion. This exposes epithelial cells to highly acidic gastric juice and pepsin, causing direct cellular injury. As damage accumulates, ulcers form and may penetrate deeper tissue layers, potentially damaging blood vessels.

H. pylori uses adhesins to bind to mucus-secreting epithelial cells. The bacterium then penetrates the protective mucus barrier and attaches directly to the epithelial surface. Once established, it multiplies and produces virulence factors that initiate pathogenic processes leading to mucosal damage.

Untreated peptic ulcers can lead to gastrointestinal bleeding, perforation, and obstruction. As ulcers deepen, they may damage blood vessels, causing internal bleeding indicated by vomiting of coffee-ground material or black, tarry stools. Vascular involvement or mucosal perforation represents a medical emergency requiring prompt intervention.

H. pylori is primarily transmitted through person-to-person spread, especially within families, likely via oral transmission during childhood. The bacterium is rarely associated with food or animal vectors. Prevalence is significantly higher in developing countries with poor sanitation and crowded living conditions, similar to patterns seen in bacterial gastroenteritis.

Chronic H. pylori infections increase the risk of gastric malignancies, including MALT lymphomas and gastric carcinoma. These outcomes result from persistent inflammation and disruption of mucosal immunity and cellular regulation. Early detection and treatment of H. pylori infection can reduce these serious complications.